Unlike GPC3 CAR-T cells, CD133 CAR-T cells not only block the nutritional supply to tumor cells but also are used in combination with other drugs to treat hepatocellular carcinoma (87). The gene discussed is PROM1; the disease is hepatocellular carcinoma.